Onconetix, Inc. Excess Stock, Shares Outstanding
Onconetix, Inc. (ONCO) had Excess Stock, Shares Outstanding of 0 shares as of 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Excess Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:ExcessStockSharesOutstanding · last filed 2022-05-13
- 2022-03-31: Excess Stock, Shares Outstanding 0.00 shares.
- 2021-12-31: Excess Stock, Shares Outstanding 1.15M shares.
| Period end | Excess Stock, Shares Outstanding |
|---|---|
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-13 |
| 2021-12-31 | 1.15M shares 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |